MET Is highly expressed in advanced stages of colorectal cancer and indicates worse prognosis and mortality

Autor: Oliveira, Antonio Talvane Torres de [UNIFESP], Matos, Delcio [UNIFESP], Logullo, Angela Flavia [UNIFESP], Silva, Sandra Regina Morini da [UNIFESP], Artigiani Neto, Ricardo [UNIFESP], Longat Filho, Adhemar, Saad, Sarhan Sydney [UNIFESP]

Publikováno v: Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP

The aim of the present study was to evaluate by immunohistochemistry the prognostic meaning of the tumor marker MET (hepatocyte growth factor) in patients submitted to surgical resection due to primary colorectal adenocarcinoma. Patients and Methods:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3ab206ff95187f18c5eac49fe1b2090b